We Care About Your Project As Much As You Do

CONTACT US

Bringing process engineering, project management, quality, and regulatory expertise to all we do

For over fifty years, BIOVECTRA has been dedicated to producing quality products and effectively managing client projects. However, as our clients’ needs have become more demanding, we’ve found new ways to partner to rise to the challenges.

Our teams work to stay ahead of evolving quality requirements and the leading global agencies’ regulatory demands. Specialized quality teams carefully align to support our products as they move through the development process and ultimately to the manufacturing floor.

Upon onboarding of your project, our process engineering group works hand-in-hand with the project team to proactively address any challenges around equipment and room set-up. Additionally, BIOVECTRA has long been dedicated to effective project management to improve our clients’ experience and keep programs on track. We continue to invest heavily in project management and technology tools, increasing efficiency and advancing speed-to-market initiatives.

Display Logo Biovectra
slide2
slide3
slide4
Learn More About Our Facilities

“In the current landscape, quality requirements are changing quickly. We have been very active in working with clients to gather needed insights to meet the new regulations and leverage the insights to promote product quality and patient safety.”

—Peter Phillips, VP Quality

“We’ve made tremendous progress in applying automation and technology-enabled accountability to BIOVECTRA project management. Now, we’re positioning ourselves to advance project management analytics to constantly improve our clients’ experience and success.”

—Andrea Dawson, Senior Director, Project Management

“We’re very collaborative with our clients, and we’ve strengthened our internal collaboration capabilities, increasing our accountability to each other–improving our ability to advance projects seamlessly.”

—Lesley Whitlock, Director, Capital Projects

Integrated Process Engineering

Thorough Analysis of Technical Aspects of Client Programs and Project Suitability
Careful and early analysis of project suitability identifies potential needs for equipment optimizations and facility fit. This upfront work reduces unwanted surprises as projects progress, significantly contributing to supply assurance.

Collaboration and Adaptability
Whether by collaborating within our organization to solve customer problems or collaborating directly with clients, we are dedicated to exceptional results. Our process engineering team paves the way as new requirements, approaches, and technologies are explored and implemented. 

Dedicated Project Management

Empowered Project Management Team Improves Clients’ Experiences
We empower our project management team to lead projects throughout a product’s life cycle. Project managers review the process from all angles to map out a custom onboarding process, allowing us to be on time and schedule while producing high-quality products.

Broad Project Management Expertise
We benefit from a lot of cross-pollination within the organization. The net result is embedding quality and project management expertise in all that we do. A project manager is assigned as your primary point of contact for every project. They have diverse backgrounds and are established leaders with problem-solving mindsets.  

Proactive Timeline Resource Management
We’re willing to add resources to meet tight timelines allowing clients to reach market delivery objectives.

Matured Quality System

Quality Dedication Improves Efficiencies
Our quality system includes all of the needed components such as training and traceability. This allows us to maximize on-time runs, achieve required product yields, ultimately resulting in the best possible cost of goods for our clients. 

Quality Risk Management Approach
Thorough characterization of both products and processes facilitates highly effective decision-making by collaborating with our clients and among our internal team.

Specialized Quality Team Alignment
We continue to strengthen specialization areas among our quality teams and align those specializations to product life cycle stages, improving product quality and efficiency. BIOVECTRA takes a phase-appropriate approach to quality, and we continue expanding our expertise and capabilities to best serve our clients. As just one example, we see many requests for new types of impurity qualification and process characterization.

Demonstrated Regulatory Support

Established Relationships with Regulatory Agencies
We lay the proper foundation for your project’s regulatory needs by working closely with global regulatory agencies, especially FDA and Health Canada. Our strong performance with the regulatory agencies demonstrates our strict compliance with pharmaceutical processing standards and our commitment to deliver safe and effective products to our customers.

Strong Track Record of Successful Inspections
Our Quality Management System, operated across all sites based (on ICH Q7 and Q10), is monitored and regularly reviewed to ensure adherence to standards expected by our regulators, customers, and patients. This is reflected by our 15+ regulatory inspections with no critical observations.

A test tube with a purple cap, partially filled with a yellow liquid, and purple markings along its side.

Process Development

Demonstrated experience in process development and characterization, offering phase appropriate solutions and rapid optimization.

This is a stylized illustration of a computer network setup, featuring multiple connected servers and components with cables and abstract shapes.

Analytical Development

Targeted analytical support from early development to validation of commercial processes and continuous process verification, all along the life cycle of your program.

The image shows a stylized silhouette of a head with gears inside, suggesting thinking or innovation, and an arrow indicating progress or growth.

Tech Transfer

Dedicated tech transfer teams ensuring a seamless transition from development to manufacturing - collaborating with our clients with a problem-solving mindset.

A gray container and a yellow liquid-filled flask are depicted, illustrating a chemistry or industrial lab setting.

Clinical Development

Supplying our clients with pre-clinical and clinical material to enabling them to move quickly and cost-efficiently through the clinical phases.

Three large gas tanks of varying sizes are lined up, each with a circular bottom and blue stripes. Simple, stylized design.

Scale-Up

De-risking our client’s programs by effectively managing the transition from lab to pilot to manufacturing scale.

Three large, cylindrical, silver tanks in a row, likely part of an industrial setup. Blue horizontal line drawn across all three tanks.

Commercial Scale

A proven history of commercial manufacturing partnerships growing alongside our clients. Effective collaboration increasing speed-to-market.

Browse Other Areas of Expertise

Molecular structure with interconnected blue circles and one yellow circle, resembling a chemical compound or formula. No landmarks or historical buildings present.

Synthetic Small Molecules

LEARN MORE
Circular DNA structure, blue and purple strands, intertwined with yellow segments. Depicts molecular biology, genetics, and DNA replication concepts with stylized visuals.

mRNA/pDNA

LEARN MORE
This appears to be a pair of illustrated purple gloves with blue cuffs, positioned vertically, surrounded by a blue square border.

High Potency APIs

LEARN MORE
A pipette drops liquid into three test tubes on a stand, indicating a scientific experiment or lab activity.

Bioreagents

LEARN MORE
Abstract design featuring interlocking blue and orange shapes with DNA-like elements, forming a circular pattern. No recognizable landmarks or historical buildings present.

Biologics

LEARN MORE

Ready to learn how BIOVECTRA can help? Contact us today!

SEO plus – Test

  • 20+ years at GSK, leading R&D activities on multiple vaccine programs
  • Recently held positions in industry include: Senior Director (Function Head), Protein Biochemistry; Director, Antigen Design & Prototype Production; and, Associate Director, Antigen Design and Protein Characterization.
  • Key areas of expertise are:
    • Process development of protein Biologics/Recombinant Antigens
    • Recombinant protein expression (mammalian, insect, yeast, bacterial)
    • Production/design of Viral Vectors, mRNA vaccines, Bacterial outer membrane vesicles
    • Protein Engineering and Structural Biology
    • Defining quality attributes, biophysical characterization of proteins, and analytical strategy
  • Post graduate degrees in Functional Genomics (Université Laval) and Bioinformatics (MIT); M. Sc. Microbiology and Immunology (Laval).
  • 25+ Patent & 5 Scientific Publications

Normand Blais – Senior Director Development & Innovation, Biologics

  • 20+ years at GSK, leading R&D activities on multiple vaccine programs
  • Recently held positions in industry include: Senior Director (Function Head), Protein Biochemistry; Director, Antigen Design & Prototype Production; and, Associate Director, Antigen Design and Protein Characterization.
  • Key areas of expertise are:
    • Process development of protein Biologics/Recombinant Antigens
    • Recombinant protein expression (mammalian, insect, yeast, bacterial)
    • Production/design of Viral Vectors, mRNA vaccines, Bacterial outer membrane vesicles
    • Protein Engineering and Structural Biology
    • Defining quality attributes, biophysical characterization of proteins, and analytical strategy
  • Post graduate degrees in Functional Genomics (Université Laval) and Bioinformatics (MIT); M. Sc. Microbiology and Immunology (Laval).
  • 25+ Patent & 5 Scientific Publications

Oliver Technow - Chief Executive Officer

  • Industry Master Degree from Frankfurt Chamber of Commerce, Frankfurt Germany.
  • More than 20 years of global pharmaceutical industry experience.
  • Held numerous leadership positions in commercial development, marketing and brand management, and lifecycle management and has extensive product launch and market access expertise in Europe and North America.
  • In 1997, joined Eisai GmbH in Frankfurt, Germany and in 2002, was appointed Director, CNS Business Unit; in 2006, was appointed Vice President, Head of Global Marketing for Eisai Inc. in Woodcliff Lake, NJ;  in 2011, was appointed Vice President, Established Products Business Unit; in 2013, was appointed President & General Manager for Eisai Limited in Mississauga, ON.
  • Appointed President of BIOVECTRA Inc., December 10, 2015.
  • Board Director for BIOTECanada
  • Member of the Steering Council of Innovative Medicines Canada (IMC)
  • In 2017, appointed to the Government of Canada’s Health/Bio-sciences Strategic Economic Table
  • In November 2019, promoted to Chief Executive Officer at BIOVECTRA
  • In June 2020, named new Chair of PEI BioAlliance Board of Directors